← Eichor
Study identifier: NCT06921746 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients

Condition: Overactive Bladder  ·  Sponsor: University Hospital Ostrava

PhaseN/A
Planned participants80
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a non-interventional study that will not pose any burden for the participants. The study subjects will be examined and treated in a standard manner according to current clinical recommendations for the treatment of overactive bladder (OAB). A portion of urine samples, which are routinely collected for biochemical and culture examinations as part of the diagnostic process, will be sent for examination of the characteristics of the urinary microbiome and metabolome (UMM) before and after treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Jiří Hynčica  ·  0042059737  ·  jiri.hyncica@fno.cz

Always discuss trial participation with your own doctor first.

Locations (4)

University Hospital OstravaOstrava, Moravian-Silesian Region, CzechiaRecruiting
Thomayer University HospitalPrague, CzechiaRecruiting
Institute of Microbiology of the Czech Academy of SciencesPrague, CzechiaRecruiting
University Hospital BulovkaPrague, CzechiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06921746